Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures

American Journal of Geriatric Psychiatry

Volumn 21, Issue 8, 2013, Pages 785-793

  Mangoni, Arduino A ^a,b   Munster, Barbara C Van ^c,d   Woodman, Richard J ^e   Rooij, Sophia E De ^c  

^a Section of Translational Medical Sciences   (United Kingdom)

^b WOODEND HOSPITAL   (United Kingdom)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d GELRE HOSPITALS   (Netherlands)

^e FLINDERS UNIVERSITY   (Australia)

Author keywords

Anticholinergic drug scoring systems; Cognitive impairment; Delirium; Mortality; Older patients; Serum anticholinergic activity

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

AGED; ANTICHOLINERGIC BURDEN SCALE; ANTICHOLINERGIC COMPONENT OF THE DRUG BURDEN INDEX; ANTICHOLINERGIC DRUG SCALE; ANTICHOLINERGIC RISK SCALE; ARTICLE; COGNITIVE DEFECT; DELIRIUM; DRUG ACTIVITY; DRUG BLOOD LEVEL; FEMALE; HIP FRACTURE; HIP SURGERY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; RATING SCALE; SERUM ANTICHOLINERGIC ACTIVITY;

ANTICHOLINERGIC DRUG SCORING SYSTEMS; COGNITIVE IMPAIRMENT; DELIRIUM; MORTALITY; OLDER PATIENTS; SERUM ANTICHOLINERGIC ACTIVITY;

AGE FACTORS; AGED, 80 AND OVER; CHOLINERGIC ANTAGONISTS; COGNITION DISORDERS; DELIRIUM; FEMALE; HIP FRACTURES; HUMANS; LENGTH OF STAY; MALE; POSTOPERATIVE COMPLICATIONS;

EID: 84884658777     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2013.01.012     Document Type: Article

References (41)

1. Bostock CV, Soiza RL, Mangoni AA: Association between prescribing of antimuscarinic drugs and antimuscarinic adverse effects in older people. Expert Rev Clin Pharmacol 2010; 3(4): 441-452
2. Feinberg M: The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993; 3(4): 335-348
3. Dyer CB, Ashton CM, Teasdale TA: Postoperative delirium. A review of 80 primary data-collection studies. Arch Intern Med 1995; 155(5): 461-465
4. Han L, McCusker J, Cole M, et al: Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001; 161(8): 1099-1105
5. Rudolph JL, Salow MJ, Angelini MC, et al: The Anticholinergic Risk Scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008; 168(5): 508-513
6. Carnahan RM, Lund BC, Perry PJ, et al: The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol 2006; 46(12): 1481-1486
7. Hilmer SN, Mager DE, Simonsick EM, et al: A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007; 167(8): 781-787
8. Fox C, Richardson K, Maidment ID, et al: Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study [published online ahead of print June 24, 2011]. J Am Geriatr Soc 2011; 59(8): 1477-1483
9. Hilmer SN, Mager DE, Simonsick EM, et al: Drug burden index score and functional decline in older people. Am J Med 2009; 122(12): 1142-1149
10. Lowry E, Woodman RJ, Soiza RL, et al: Associations between the Anticholinergic Risk Scale score and physical function: potential implications for adverse outcomes in older hospitalized patients. J Am Med Dir Assoc 2011; 12(8): 565-572
11. Agar M, To T, Plummer J, et al: Anti-cholinergic load, health care utilization, and survival in people with advanced cancer: a pilot study. J Palliat Med 2010; 13(6): 745-752
12. Turbanti L, Subissi A, Bramanti G: Antimuscarinic drugs: traditional and potential new therapeutic agents. Pharmacol Res Commun 1982; 14(10): 923-940
13. Tune L, Coyle JT: Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry 1980; 37(3): 293-297
14. Chew ML, Mulsant BH, Pollock BG, et al: Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc 2008; 56(7): 1333-1341
15. Carnahan RM, Lund BC, Perry PJ, et al: A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practice. Psychopharmacol Bull 2002; 36(2): 24-39
16. Mangoni AA, Jackson SH: Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57(1): 6-14
17. Jorm AF, Jacomb PA: The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989; 19(4): 1015-1022
18. Katz S: Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 1983; 31(12): 721-727
19. Inouye SK, van Dyck CH, Alessi CA, et al: Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990; 113(12): 941-948
20. Schuurmans MJ, Shortridge-Baggett LM, Duursma SA: The Delirium Observation Screening Scale: a screening instrument for delirium. Res Theory Nurs Pract 2003; 17(1): 31-50
21. D'Hoore W, Sicotte C, Tilquin C: Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 1993; 32(5): 382-387
22. Boustani MA, Campbell N, Munger S, et al: Impact of anticholinergics on the aging brain: a review and practical application. Aging Health 2008; 4(3): 311-320
23. Mulsant BH, Pollock BG, Kirshner M, et al: Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 2003; 60(2): 198-203
24. Mach JR Jr, Dysken MW, Kuskowski M, et al: Serum anticholinergic activity in hospitalized older persons with delirium: a preliminary study. J Am Geriatr Soc 1995; 43(5): 491-495
25. Vinogradov S, Fisher M, Warm H, et al: The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. Am J Psychiatry 2009; 166(9): 1055-1062
26. Chew ML, Mulsant BH, Pollock BG: Serum anticholinergic activity and cognition in patients with moderate-to-severe dementia. Am J Geriatr Psychiatry 2005; 13(6): 535-538
27. Nebes RD, Pollock BG, Halligan EM, et al: Serum anticholinergic activity and motor performance in elderly persons. J Gerontol A Biol Sci Med Sci 2007; 62(1): 83-85
28. Plaschke K, Thomas C, Engelhardt R, et al: Significant correlation between plasma and CSF anticholinergic activity in presurgical patients. Neurosci Lett 2007; 417(1): 16-20
29. Cox EA, Kwatra SG, Shetty S, et al: Flaws in the serum anticholinergic activity assay: implications for the study of delirium. J Am Geriatr Soc 2009; 57(9): 1707-1708
30. Flacker JM, Wei JY: Endogenous anticholinergic substances may exist during acute illness in elderly medical patients. J Gerontol A Biol Sci Med Sci 2001; 56(6):M353-M355
31. Flacker JM, Lipsitz LA: Serum anticholinergic activity changes with acute illness in elderly medical patients. J Gerontol A Biol Sci Med Sci 1999; 54(1):M12-M16
32. Brecht S, Reiff J, Vock U, et al: Serum anticholinergic activity in patients following cardiac surgery and healthy individuals following amitriptyline application. Methods Find Exp Clin Pharmacol 2007; 29(3): 223-230
33. Mangoni AA: Assessing the adverse effects of antimuscarinic drugs in older patients: which way forward? Expert Rev Clin Pharmacol 2011; 4(5): 531-533
34. Wilson NM, Hilmer SN, March LM, et al: Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc 2011; 59(5): 875-880
35. Lowry E, Woodman RJ, Soiza RL, et al: Drug Burden Index, physical function, and adverse outcomes in older hospitalized patients [published online ahead of print December 13, 2011]. J Clin Pharmacol DOI: 10.1177/0091270011421489
36. Nebes RD, Pollock BG, Meltzer CC, et al: Serum anticholinergic activity, white matter hyperintensities, and cognitive performance. Neurology 2005; 65(9): 1487-1489
37. Hori K, Konishi K, Watanabe K, et al: Influence of anticholinergic activity in serum on clinical symptoms of Alzheimer's disease. Neuropsychobiology 2011; 63(3): 147-153
38. Plaschke K, Kopitz J, Mattern J, et al: Increased cortisol levels and anticholinergic activity in cognitively unimpaired patients. J Neuropsychiatry Clin Neurosci 2010; 22(4): 433-441
39. Burgos E, Gomez-Arnau JI, Diez R, et al: Predictive value of six risk scores for outcome after surgical repair of hip fracture in elderly patients. Acta Anaesthesiol Scand 2008; 52(1): 125-131
40. Vidal EI, Coeli CM, Pinheiro RS, et al: Mortality within 1 year after hip fracture surgical repair in the elderly according to postoperative period: a probabilistic record linkage study in Brazil. Osteoporos Int 2006; 17(10): 1569-1576
41. Wiles MD, Moran CG, Sahota O, et al: Nottingham Hip Fracture Score as a predictor of one year mortality in patients undergoing surgical repair of fractured neck of femur. Br J Anaesth 2011; 106(4): 501-504